Diffuse large B cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency | The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency. | ||
==Risk factors== | ==Risk factors== | ||
* An underlying [[immunodeficiency]] is a significant risk factor. | * An underlying [[immunodeficiency]] is a significant risk factor. | ||
==References== | ==References== | ||
Revision as of 22:01, 24 August 2015
|
Diffuse large B cell lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diffuse large B cell lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of Diffuse large B cell lymphoma risk factors |
|
Directions to Hospitals Treating Diffuse large B cell lymphoma |
|
Risk calculators and risk factors for Diffuse large B cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The most potent risk factor in the development of diffuse large B cell lymphoma is immunodeficiency.
Risk factors
- An underlying immunodeficiency is a significant risk factor.